Karen L. Zaderej
CEO at Axogen Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Axogen Inc., 3 years.
Axogen Inc.
Director · CEO
EyePoint Inc.
Director
Chief executive roles
Axogen Inc.
· CEO
Until August 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 11, 2025 | EyePoint Inc. | Option exercise | +2,000 | — | — |
| May 19, 2025 | EyePoint Inc. | Open-market purchase | +5,000 | $5.99 | $29,950 |
| May 16, 2025 | EyePoint Inc. | Open-market purchase | +5,000 | $5.81 | $29,050 |
| May 15, 2025 | EyePoint Inc. | Open-market purchase | +5,000 | $5.47 | $27,350 |
| May 14, 2025 | EyePoint Inc. | Open-market purchase | +5,000 | $5.42 | $27,100 |
| Aug 19, 2024 | EyePoint Inc. | Open-market purchase | +12,500 | $7.98 | $99,750 |
| Jul 11, 2024 | EyePoint Inc. | Option exercise | +2,000 | — | — |
| Mar 21, 2024 | Axogen Inc. | Open-market sale | −33,028 | $7.68 | $253,655 |
| Mar 21, 2024 | Axogen Inc. | Open-market sale | −3,086 | $7.68 | $23,700 |
| Mar 21, 2024 | Axogen Inc. | Open-market sale | −3,166 | $7.68 | $24,315 |
| Mar 16, 2024 | Axogen Inc. | Option exercise | +84,847 | — | — |
| Mar 16, 2024 | Axogen Inc. | Option exercise | +12,500 | — | — |
| Mar 16, 2024 | Axogen Inc. | Option exercise | +12,975 | — | — |
| Jul 18, 2023 | Axogen Inc. | Grant or award | +22,076 | — | — |
| Jul 11, 2023 | EyePoint Inc. | Option exercise | +2,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.